Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
KAUFMAN, Bella, MACKEY, John R, REVIL, Cédric, JONES, Alison, CLEMENS, Michael R, BAPSY, Poonamalle P, VAID, Ashok, WARDLEY, Andrew, TJULANDIN, Sergei, JAHN, Michaela, LEHLE, Michaela, FEYEREISLOVA, Andrea
Published in Journal of clinical oncology (20.11.2009)
Published in Journal of clinical oncology (20.11.2009)
Get full text
Journal Article
Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
VON MINCKWITZ, Gunter, DU BOIS, Andreas, BAUMANN, Klaus H, CLEMENS, Michael R, DUERR, Ralph, ULEER, Christoph, ANDERSSON, Michael, STEIN, Robert C, NEKIJUDOVA, Valentina, LOIBL, Sibylle, SCHMIDT, Marcus, MAASS, Nicolai, CUFER, Tanja, DE JONGH, Felix E, MAARTENSE, Eduard, ZIELINSKI, Christoph, KAUFMANN, Manfred, BAUER, Wolfgang
Published in Journal of clinical oncology (20.04.2009)
Published in Journal of clinical oncology (20.04.2009)
Get full text
Journal Article
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104
Kruger, Stephan, Boeck, Stefan, Heinemann, Volker, Laubender, Ruediger P., Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C., Fischer von Weikersthal, Ludwig, Clemens, Michael R., Geissler, Michael, Greten, Tim F., Hegewisch-Becker, Susanna, Modest, Dominik P., Stintzing, Sebastian, Haas, Michael
Published in Acta oncologica (01.07.2015)
Published in Acta oncologica (01.07.2015)
Get full text
Journal Article
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer
Clemens, Michael R., Gladkov, Oleg A., Gartner, Elaina, Vladimirov, Vladimir, Crown, John, Steinberg, Joyce, Jie, Fei, Keating, Anne
Published in Breast cancer research and treatment (01.01.2015)
Published in Breast cancer research and treatment (01.01.2015)
Get full text
Journal Article
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the ‘Arbeitsgemeinschaft Internistische Onkologie’ (AIO-PK0104)
Heinemann, Volker, Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C, von Weikersthal, Ludwig Fischer, Clemens, Michael R, Geissler, Michael, Greten, Tim F, Hegewisch-Becker, Susanna, Rubanov, Oleg, Baake, Gerold, Höhler, Thomas, Ko, Yon D, Jung, Andreas, Neugebauer, Sascha, Boeck, Stefan
Published in Gut (01.05.2013)
Published in Gut (01.05.2013)
Get full text
Journal Article
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials
Ormanns, Steffen, Haas, Michael, Baechmann, Sibylle, Altendorf-Hofmann, Annelore, Remold, Anna, Quietzsch, Detlef, Clemens, Michael R, Bentz, Martin, Geissler, Michael, Lambertz, Helmut, Kruger, Stephan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan
Published in British journal of cancer (06.12.2016)
Published in British journal of cancer (06.12.2016)
Get full text
Journal Article
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer
Haas, Michael, Ormanns, Steffen, Baechmann, Sibylle, Remold, Anna, Kruger, Stephan, Westphalen, Christoph B, Siveke, Jens T, Wenzel, Patrick, Schlitter, Anna Melissa, Esposito, Irene, Quietzsch, Detlef, Clemens, Michael R, Kettner, Erika, Laubender, Ruediger P, Jung, Andreas, Kirchner, Thomas, Boeck, Stefan, Heinemann, Volker
Published in British journal of cancer (23.05.2017)
Published in British journal of cancer (23.05.2017)
Get full text
Journal Article
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)
von Minckwitz, Gunter, Darb-Esfahani, Silvia, Loibl, Sibylle, Huober, Jens, Tesch, Hans, Solbach, Christine, Holms, Frank, Eidtmann, Holger, Dietrich, Klaus, Just, Marianne, Clemens, Michael R., Hanusch, Claus, Schrader, Iris, Henschen, Stephan, Hoffmann, Gerald, Tiemann, Katharina, Diebold, Kurt, Untch, Michael, Denkert, Carsten
Published in Breast cancer research and treatment (01.04.2012)
Published in Breast cancer research and treatment (01.04.2012)
Get full text
Journal Article
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104
Ormanns, Steffen, Siveke, Jens T, Heinemann, Volker, Haas, Michael, Sipos, Bence, Schlitter, Anna Melissa, Esposito, Irene, Jung, Andreas, Laubender, Rüdiger P, Kruger, Stephan, Vehling-Kaiser, Ursula, Winkelmann, Cornelia, Fischer von Weikersthal, Ludwig, Clemens, Michael R, Gauler, Thomas C, Märten, Angela, Geissler, Michael, Greten, Tim F, Kirchner, Thomas, Boeck, Stefan
Published in BMC cancer (28.08.2014)
Published in BMC cancer (28.08.2014)
Get full text
Journal Article
Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'
Boeck, Stefan, Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Märten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas, Fischer von Weikersthal, Ludwig, Clemens, Michael R, Geissler, Michael, Greten, Tim F, Hegewisch-Becker, Susanna, Neugebauer, Sascha, Heinemann, Volker
Published in Anti-cancer drugs (01.01.2010)
Published in Anti-cancer drugs (01.01.2010)
Get more information
Journal Article
Impact of SPARC expression level on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: A pooled analysis from prospective clinical and translational trials
Ormanns, Steffen, Haas, Michael, Baechmann, Sibylle, Remold, Anna, Quietzsch, Detlef, Clemens, Michael R., Bentz, Martin, Schoppmeyer, Konrad, Kruger, Stephan, Kirchner, Thomas, Heinemann, Volker, Boeck, Stefan Hubert
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Prospective WSG phase III PlanB trial: Final analysis of adjuvant 4xEC→4x doc vs. 6x docetaxel/cyclophosphamide in patients with high clinical risk and intermediate-to-high genomic risk HER2-negative, early breast cancer
Harbeck, Nadia, Gluz, Oleg, Clemens, Michael R., Malter, Wolfram, Reimer, Toralf, Nuding, Benno, Aktas, Bahriye, Stefek, Andrea, Pollmanns, Anke, Lorenz-Salehi, Fatemeh, Uleer, Christoph, Krabisch, Petra, Kummel, Sherko, Liedtke, Cornelia, Shak, Steven, Wuerstlein, Rachel, Christgen, Matthias, Kates, Ronald, Kreipe, Hans Heinrich, Nitz, Ulrike
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase II randomized, open-label study of YM155 (sepantronium bromide) plus docetaxel versus docetaxel alone as first-line treatment for HER2 negative metastatic breast cancer
Clemens, Michael R., Keating, Anne Therese, Gladkov, Oleg, Jie, Fei, Steinberg, Joyce, Gartner, Elaina M., Crown, John, Vladimirov, Vladimir Ivanovich
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Prognostic impact of androgen receptor (AR) and forkhead box A1 (FOXA1) in early HER2-negative primary breast cancer: A translational substudy of the prospective phase III WSG-PlanB-trial
Degenhardt, Tom, Kreipe, Hans Heinrich, Gluz, Oleg, Kates, Ronald E., Liedtke, Cornelia, Kraemer, Stefan, Clemens, Michael R., Nuding, Benno, Reimer, Toralf, Aktas, Bahriye, Kummel, Sherko, Just, Marianne, Lorenz-Salehi, Fatemeh, Uleer, Christoph, Stefek, Andrea, Heyl, Volker, Wuerstlein, Rachel, Nitz, Ulrike, Harbeck, Nadia, Christgen, Matthias
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A randomized phase III trial comparing nanoparticle-based paclitaxel with solvent-based paclitaxel as part of neoadjuvant chemotherapy for patients with early breast cancer (GeparSepto): GBG 69
Jackisch, Christian, Wiebringhaus, Frank, Conrad, Bettina, Weigel, Michael, Aktas, Bahriye, Wagner, Harald, Latos, Kunibert, Kohls, Andreas, Bueckner, Ute, Hauzenberger, Tanja, Bangemann, Nikola, Hackmann, John, Clemens, Michael R., Heinrich, Bernhard, Tome, Oliver, Loibl, Sibylle, Nekljudova, Valentina, Von Minckwitz, Gunter
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Persistence of HER2 overexpression on circulating tumor cells in patients after systemic treatment for HER2-positive breast cancer: Follow-up results of the German Success B trial
Neugebauer, Julia Katharina, Rack, Brigitte Kathrin, Jaeger, Bernadette Anna Sophia, Andergassen, Ulrich, Pestka, Aurelia, Fasching, Peter A., Friedl, Thomas W. P., Mouarrawy, Doraid, Clemens, Michael R., Ziemendorff, Gabriele, Heinrich, Georg, von Abel, Ekkehard, Schneeweiss, Andreas, Beckmann, Matthias W., Pantel, Klaus, Janni, Wolfgang
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Phosphorylated ERK (pERK) as biomarker in patients with advanced pancreatic cancer treated with erlotinib within a randomized phase III trial (AIO-PK0104)
Boeck, Stefan Hubert, Ormanns, Steffen, Laubender, Ruediger Paul, Jung, Andreas, Siveke, Jens T, Haas, Michael, Neumann, Jens, Vehling-Kaiser, Ursula, Winkelmann, Cornelia, Fischer von Weikersthal, Ludwig, Clemens, Michael R., Gauler, Thomas C., Marten, Angela, Klein, Stefan, Kojouharoff, Georgi, Geissler, Michael, Greten, Tim F, Kirchner, Thomas, Heinemann, Volker
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
Prospective comparison of recurrence score and independent central pathology assessment of prognostic tools in early breast cancer (BC): Focus on HER2, ER, PR, Ki-67 results from the phase III WSG-Plan B trial
Gluz, Oleg, Kreipe, Hans Heinrich, Christgen, Matthias, Degenhardt, Tom, Kates, Ronald E., Liedtke, Cornelia, Shak, Steven, Clemens, Michael R., Salem, Marwa, Markmann, Susanne, Liedtke, Bernd, Aktas, Bahriye, Henschen, Stephan, Pollmanns, Anke, Krabisch, Petra, Uleer, Christoph, Augustin, Doris, Thomssen, Christoph, Nitz, Ulrike, Harbeck, Nadia
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article